Douglas S. Hawkins, MD
Specialty:
Cancer / Blood Disorders
Associate Division Chief, Pediatric Hematology/Oncology, Seattle Children's Hospital
Associate Professor of Pediatrics, UW School of Medicine
Dr. Douglas Hawkins joined Seattle Children's Hospital in 1996. Dr. Hawkins is the principal investigator for Children's Oncology Group (COG) activity at Seattle Children's, associate editor of the Journal of Pediatric Hematology/Oncology and vice chair of the COG Soft Tissue Sarcoma Committee. He is a member of several COG committees, including the soft tissue sarcoma, bone tumor, and voting body steering committees. Dr. Hawkins has focused on clinical research, particularly in the treatment of pediatric sarcomas. He is the COG chair of two clinical trials, one for Ewing sarcoma and another for rhabdomyosarcoma, and vice chair of three other COG clinical trials. He is collaborating on a pharmacogenomic study investigating cyclophospharmide metabolism and toxicity, both locally and as part of two COG studies. In addition, he collaborates on the use of the fluorodeoxyglucose positron emission tomography (FDG-PET) scan to assess response and guide treatment in pediatric sarcomas.
Professional history:
Board Certified: Pediatric Hematology-Oncology
Medical School: Harvard Medical School, Boston
Residency: University of Washington, Seattle
To schedule an interview with Dr. Hawkins, please contact the Public Relations department.